Nuclea Biotechnologies Inc. - Product Pipeline Analysis

1
Nuclea Biotechnologies Inc. - Product Pipeline
AnalysisMarket Research Reports Distributor
- Aarkstore.com have vast database on market
research reports, company financials, company
profiles, SWOT analysis, company report, company
statistics, strategy review, industry report,
industry research to provide excellent and
innovative service to our report
buyers.Aarkstore.com have very interactive
search feature to browse across more than
2,50,000 business industry reports. We are built
on the premise that reading is valuable, capable
of stirring emotions and firing the imagination.
Whether you're looking for new market research
report product trends or competitive industry
analysis of a new or existing market,
Aarkstore.com has the best resource offerings and
the expertise to make sure you get the right
product every time.
2
Nuclea Biotechnologies Inc. - Product Pipeline
Analysis

• SummaryNuclea Biotechnologies Inc. (Nuclea) is
  a translational medicine company. It carries out
  the discovery of proprietary biomarkers and in
  vitro companion diagnostic assays. The companys
  vitro companion diagnostics are used in
  therapeutic and medical imaging applications
  colon, stomach, leukemia, lung and prostate.
  Nuclea develops companion diagnostics for other
  disease indications such as cardiovascular,
  inflammation, metabolic disorders and
  neurological. It conducts research leading to
  novel molecular oncology therapeutics and
  diagnostics for the pharmaceutical and
  biotechnology industries. Nuclea is headquartered
  in Pittsfield, Massachusetts, the US. Nuclea
  aims to expand its product offering and drive
  significant licensing revenue. To this end, the
  company acquired a portfolio containing six
  patents and applications related to tissue
  microarrays from Laurus Master Fund, Ltd.This
  report is a source for data, analysis and
  actionable intelligence on the Nuclea
  Biotechnologies Inc. portfolio of pipeline
  products. The report provides detailed analysis
  on each pipeline product with information on the
  indication, the development stage, trial phase,
  product milestones, pipeline territory, estimated
  approval date, and estimated launch dateEach
  pipeline product is profiled to cover information
  on product description, function, technology,
  indication, and application. The report is also
  supplemented with a detailed company profile and
  information on clinical trials, wherever
  applicable.This report is built using data and
  information sourced from proprietary databases,
  primary and secondary research and in-house
  analysis by GlobalDatas team of industry experts.

3

• Scope- Detailed company profile with
  information on business description, key company
  facts, major products and services, key
  competitors, key employees, locations and
  subsidiaries and recent developments.- Detailed
  coverage on all the pipeline products, by
  equipment type, by therapy area, by development
  stage, and by trial phase.- Information on
  product milestones and pipeline territory for
  each product, the estimated approval date, and
  estimated launch date.- Profile of each pipeline
  product with additional information on product
  description, function, technology, indication(s),
  and application.- Data on relevant clinical
  trials and product patent details, wherever
  applicable.- Information on clinical trial,
  wherever applicable, is supplemented with
  information on trial phase, trial status, trial
  objective, trial design, target patients, unique
  physician identifier, primary point, secondary
  point, acronym, participants inclusion,
  participants exclusion, interventions, trial
  results, trial start date, trial end date, study
  type, trial site, trial funding, age eligibility,
  and gender eligibility.
• Reasons to Buy- Develop business strategies by
  understanding the trends and developments driving
  the medical devices pipeline and technology
  landscape globally.- Design and develop your
  product development, marketing and sales
  strategies.- Exploit MA opportunities by
  identifying market players with the most
  innovative pipeline.- Develop market-entry and
  market expansion strategies.- Exploit
  in-licensing and out-licensing opportunities by
  identifying products, most likely to ensure a
  robust return.- Identify emerging players with
  potentially strong product portfolio and create
  effective counter-strategies to gain competitive
  advantage.- Develop competition strategies by
  identifying the status and likely launch of your
  competitors pipeline products through review of
  the clinical trials, stage and phase of
  development, etc.- Which are the next high-value
  products that your competitor would add in its
  portfolio? identify, understand and capitalize.

4

• List of Tables 4List of Figures 4Key Facts
  5Nuclea Biotechnologies Inc. - Major Products
  and Services 6Nuclea Biotechnologies Inc.
  Pipeline Products by Equipment Type 7Nuclea
  Biotechnologies Inc. Pipeline Products by
  Development Stage 9Nuclea Biotechnologies Inc.
  Pipeline Products by Therapy Area 11Bone
  Metastases Diagnostic Test 13Bone Metastases
  Diagnostic Test Product Status 13Bone Metastases
  Diagnostic Test Product Description 13Breast
  Calcification Diagnostic Test 14Breast
  Calcification Diagnostic Test Product Status
  14Breast Calcification Diagnostic Test Product
  Description 14Cardiac Serum Diagnostic Assay -
  Stage A 15Cardiac Serum Diagnostic Assay - Stage
  A Product Status 15Cardiac Serum Diagnostic
  Assay - Stage A Product Description 15Cardiac
  Serum Diagnostic Assay - Stage B 16Cardiac Serum
  Diagnostic Assay - Stage B Product Status
  16Cardiac Serum Diagnostic Assay - Stage B
  Product Description 16Cardiac Serum Diagnostic
  Assay - Stage C 17Cardiac Serum Diagnostic Assay
  - Stage C Product Status 17Cardiac Serum
  Diagnostic Assay - Stage C Product Description
  17Cardiac Serum Diagnostic Assay - Stage D
  18Cardiac Serum Diagnostic Assay - Stage D
  Product Status 18Cardiac Serum Diagnostic Assay
  - Stage D Product Description 18CML Detection
  Test 19
• CML Detection Test Product Status 19CML
  Detection Test Product Description 19Colon
  Cancer Recurrence Diagnostic Test 20Colon Cancer
  Recurrence Diagnostic Test Product Status
  20Colon Cancer Recurrence Diagnostic Test
  Product Description 20

5

• EAS Prostate Cancer Diagnostic Test 21EAS
  Prostate Cancer Diagnostic Test Product Status
  21EAS Prostate Cancer Diagnostic Test Product
  Description 21EGFR TK Sensitivity Lung Cancer
  Diagnostic Test 22EGFR TK Sensitivity Lung
  Cancer Diagnostic Test Product Status 22EGFR TK
  Sensitivity Lung Cancer Diagnostic Test Product
  Description 22Irinotecan Sensitivity Diagnostic
  Test - Colon Cancer 23Irinotecan Sensitivity
  Diagnostic Test - Colon Cancer Product Status
  23Irinotecan Sensitivity Diagnostic Test - Colon
  Cancer Product Description 23MLL Detection Test
  24
• MLL Detection Test Product Status 24MLL
  Detection Test Product Description 24Prognostic
  Assay - Breast Cancer 25Prognostic Assay -
  Breast Cancer Product Status 25Prognostic Assay
  - Breast Cancer Product Description 25Nuclea
  Biotechnologies Inc. - Key Competitors 26Nuclea
  Biotechnologies Inc. - Key Employees 27Nuclea
  Biotechnologies Inc. - Key Employee Biographies
  28Nuclea Biotechnologies Inc. - Locations And
  Subsidiaries 29Head Office 29Other Locations
  Subsidiaries 29Appendix 30Methodology 30About
  GlobalData 30Contact Us 30Disclaimer 30

6
List of Tables Nuclea Biotechnologies Inc., Key
Facts 1Nuclea Biotechnologies Inc. Key Pipeline
Products by Equipment Type 1Nuclea
Biotechnologies Inc. Key Pipeline Products by
Development Stage 1Nuclea Biotechnologies Inc.,
Key Facts 5Nuclea Biotechnologies Inc., Major
Products and Services 6Nuclea Biotechnologies
Inc. Number of Pipeline Products by Equipment
Type 7Nuclea Biotechnologies Inc. Pipeline
Products by Equipment Type 8Nuclea
Biotechnologies Inc. Number of Pipeline Products
by Development Stage 9Nuclea Biotechnologies
Inc. Pipeline Products by Development Stage
10Nuclea Biotechnologies Inc. Number of Pipeline
Products by Therapy Area 11Nuclea
Biotechnologies Inc. Pipeline Products by Therapy
Area 12Bone Metastases Diagnostic Test - Product
Status 13Bone Metastases Diagnostic Test -
Product Description 13Breast Calcification
Diagnostic Test - Product Status 14Breast
Calcification Diagnostic Test - Product
Description 14Cardiac Serum Diagnostic Assay -
Stage A - Product Status 15Cardiac Serum
Diagnostic Assay - Stage A - Product Description
15Cardiac Serum Diagnostic Assay - Stage B -
Product Status 16Cardiac Serum Diagnostic Assay
- Stage B - Product Description 16Cardiac Serum
Diagnostic Assay - Stage C - Product Status
17Cardiac Serum Diagnostic Assay - Stage C -
Product Description 17Cardiac Serum Diagnostic
Assay - Stage D - Product Status 18Cardiac Serum
Diagnostic Assay - Stage D - Product Description
18CML Detection Test - Product Status 19CML
Detection Test - Product Description 19Colon
Cancer Recurrence Diagnostic Test - Product
Status 20Colon Cancer Recurrence Diagnostic Test
- Product Description 20 List of
Figures Nuclea Biotechnologies Inc. Pipeline
Products by Equipment Type 7Nuclea
Biotechnologies Inc. Pipeline Products by
Development Stage 9Nuclea Biotechnologies Inc.
Pipeline Products by Therapy Area 11 
7

• For more information, please visit
• http//www.aarkstore.com/reports/Nuclea-Biotechnol
  ogies-Inc-Product-Pipeline-Analysis-240117.html
• Or email us at contact_at_aarkstore.com or call
  919272852585
• Related Reports
• 2013 French Hospital Hematology and Flow
  Cytometry Market
• United Arab Emirates In Vitro Diagnostics
  Investment Opportunities, Analysis and Forecasts
  to 2018
• Chile In Vitro Diagnostics Investment
  Opportunities, Analysis and Forecasts to 2018
• Norway In Vitro Diagnostics Investment
  Opportunities, Analysis and Forecasts to 2018
• Aleva Neurotherapeutics SA - Product Pipeline
  Analysis.
• DiaPat GmbH - Product Pipeline Analysis.
• Manhattan Scientifics, Inc. (MHTX) - Product
  Pipeline Analysis.
• MicroTransponder Inc. - Product Pipeline
  Analysis.
• Neurostream Technologies G.P. - Product Pipeline
  Analysis.
• Pop Test LLC - Product Pipeline Analysis.

8

• Contact Us
• Aarkstore Enterprise
• Tel [phone]
• Mobile No08149852585
• Email contact_at_aarkstore.com
• Website http//www.aarkstore.com
• Blog http//www.emarketreports.com
• http//teju-aarkstoreenterprise.blogspot.in
• Follow us on twitter http//twitter.com/aarkstore
  dotcom
• http//in.linkedin.com/in/aarkstore
• http//www.facebook.com/aarkstoreenterprise